CytoTronics’ $9.25 Million Initial Seed Funding

Choate represented CytoTronics in the transaction.CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, closed its $9.25 million initial seed funding, which…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now